Hair Thinning

4

Review clinical trials related to Hair Thinning. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Participants needed: 40
Trial details
Age: 18-65Biological sex: MaleType: InterventionalSponsor: Restore Biologics Holdings, Inc. dba XtresséUpdated: Jun 10, 2026Locations: 2
Eligibility criteria

Males aged 18-65 [+3]

Change in other hair treatments in 3 months prior to study enrollment. [+3]

Status: Recruiting

Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair

The goal of this clinical trial is to test how safe and effective it is to improve hair growth using an active gummy and serum combination treatment when compared to an inactive treatment combination in women with self-perceived thinning hair. The main questions this trial aims to answer are: * to confirm using photograph analytics, how much hair growth has increased in a marked area when using active treatment versus inactive treatment, and * participants assessment and satisfaction with the hair growth using scaled assessments. Participants who qualify will be asked to complete 6 to 7 visits after voluntarily consent has been given. The study is divided into two parts. In Part A participants will be randomly given either active or inactive treatment to use over 3 months. After 3 months, all participants will enter Part B of the study and will be given active treatment to use over the final 6 months of the study.

Participants needed: 85
Trial details
Age: 28-65Biological sex: FemaleType: InterventionalSponsor: The Center for Clinical and Cosmetic ResearchUpdated: Jun 27, 2025Locations: 2
Eligibility criteria

Female adults between 28-65 years of age with consistent self-perceived thinning... [+6]

Pregnant or lactating or planning to become pregnant. [+9]

Status: Recruiting

Autologous Adipose Cells Therapy

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 21-80Biological sex: AllType: InterventionalSponsor: CERM INC.Updated: May 31, 2025Locations: 2
Eligibility criteria

Outpatients who express interest in skin rejuvenation, and/or who are experienci... [+4]

Pregnancy or lactation [+7]

Status: Recruiting

Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults

The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.

Participants needed: 90
Trial details
Age: 35-55Biological sex: FemaleType: InterventionalSponsor: Ancient + BraveUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Not listed